Blomain ES - Search Results

1

New advances in models and strategies for developing anti-obesity drugs.

Kim GW, Lin JE, Blomain ES, Waldman SA. Kim GW, et al. Among authors: blomain es. Expert Opin Drug Discov. 2013 Jun;8(6):655-71. doi: 10.1517/17460441.2013.792804. Epub 2013 Apr 29. Expert Opin Drug Discov. 2013. PMID: 23621300 Free PMC article. Review.

2

Antiobesity pharmacotherapy: new drugs and emerging targets.

Kim GW, Lin JE, Blomain ES, Waldman SA. Kim GW, et al. Among authors: blomain es. Clin Pharmacol Ther. 2014 Jan;95(1):53-66. doi: 10.1038/clpt.2013.204. Epub 2013 Oct 8. Clin Pharmacol Ther. 2014. PMID: 24105257 Free PMC article. Review.

3

Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.

Lin JE, Colon-Gonzalez F, Blomain E, Kim GW, Aing A, Stoecker B, Rock J, Snook AE, Zhan T, Hyslop TM, Tomczak M, Blumberg RS, Waldman SA. Lin JE, et al. Cancer Res. 2016 Jan 15;76(2):339-46. doi: 10.1158/0008-5472.CAN-15-1467-T. Cancer Res. 2016. PMID: 26773096 Free PMC article.

4

Mechanisms of Weight Regain following Weight Loss.

Blomain ES, Dirhan DA, Valentino MA, Kim GW, Waldman SA. Blomain ES, et al. ISRN Obes. 2013 Apr 16;2013:210524. doi: 10.1155/2013/210524. eCollection 2013. ISRN Obes. 2013. PMID: 24533218 Free PMC article. Review.

5

Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis.

Blomain ES, Lin JE, Kraft CL, Trela UT, Rock JM, Aing AS, Snook AE, Waldman SA. Blomain ES, et al. Expert Rev Clin Pharmacol. 2013 Sep;6(5):557-64. doi: 10.1586/17512433.2013.827406. Epub 2013 Aug 24. Expert Rev Clin Pharmacol. 2013. PMID: 23971873 Free PMC article. Review.

6

Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.

Gibbons AV, Lin JE, Kim GW, Marszalowicz GP, Li P, Stoecker BA, Blomain ES, Rattan S, Snook AE, Schulz S, Waldman SA. Gibbons AV, et al. Among authors: blomain es. Cancer Res. 2013 Nov 15;73(22):6654-66. doi: 10.1158/0008-5472.CAN-13-0887. Epub 2013 Oct 1. Cancer Res. 2013. PMID: 24085786 Free PMC article.

7

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.

Merlino DJ, Blomain ES, Aing AS, Waldman SA. Merlino DJ, et al. Among authors: blomain es. J Clin Med. 2014 Jul 15;3(3):763-94. doi: 10.3390/jcm3030763. J Clin Med. 2014. PMID: 26237477 Free PMC article. Review.

8

Does obesity promote the development of colorectal cancer?

Blomain ES, Waldman SA. Blomain ES, et al. Expert Rev Anticancer Ther. 2016 May;16(5):465-7. doi: 10.1586/14737140.2016.1162102. Epub 2016 Mar 24. Expert Rev Anticancer Ther. 2016. PMID: 26943700 Free PMC article. No abstract available.

9

GUCY2C ligand replacement to prevent colorectal cancer.

Blomain ES, Pattison AM, Waldman SA. Blomain ES, et al. Cancer Biol Ther. 2016 Jul 2;17(7):713-8. doi: 10.1080/15384047.2016.1178429. Epub 2016 Apr 22. Cancer Biol Ther. 2016. PMID: 27104761 Free PMC article. Review.

10

Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.

Blomain ES, Merlino DJ, Pattison AM, Snook AE, Waldman SA. Blomain ES, et al. Mol Pharmacol. 2016 Sep;90(3):199-204. doi: 10.1124/mol.115.103192. Epub 2016 Jun 1. Mol Pharmacol. 2016. PMID: 27251363 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page